Bruno Gagnon
Corporate Officer/Principal at OPTHEA LIMITED
Bruno Gagnon active positions
| Companies | Position | Start | End |
|---|---|---|---|
| OPTHEA LIMITED | Corporate Officer/Principal | 30/06/2022 | - |
Career history of Bruno Gagnon
Former positions of Bruno Gagnon
| Companies | Position | Start | End |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Chief Operating Officer | - | - |
| EIDOS THERAPEUTICS, INC. | Chief Operating Officer | - | - |
Training of Bruno Gagnon
| University of Montréal | Graduate Degree |
| Université Laval | Undergraduate Degree |
Statistics
International
| United States | 3 |
| Canada | 3 |
| Australia | 2 |
Operational
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| OPTHEA LIMITED | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Private companies | 1 |
|---|---|
Eidos Therapeutics, Inc.
 Eidos Therapeutics, Inc. BiotechnologyHealth Technology Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR. The company was founded by Graef Isabella and Alhamadsheh Mamoun on August 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Bruno Gagnon
- Experience
